BIO-key International, Inc.

OTCPK:BKYI Stock Report

Market Cap: US$4.4m

BIO-key International Balance Sheet Health

Financial Health criteria checks 3/6

BIO-key International has a total shareholder equity of $4.9M and total debt of $664.3K, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are $8.2M and $3.3M respectively.

Key information

13.58%

Debt to equity ratio

US$664.29k

Debt

Interest coverage ration/a
CashUS$2.25m
EquityUS$4.89m
Total liabilitiesUS$3.26m
Total assetsUS$8.16m

Recent financial health updates

Recent updates

Analysis Article • Aug 01

We Think The Compensation For BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Looks About Right

Key Insights BIO-key International's Annual General Meeting to take place on 8th of August CEO Mike DePasquale's total...
Analysis Article • Jan 01

BIO-key International (NASDAQ:BKYI) Is Carrying A Fair Bit Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Seeking Alpha • Aug 12

BIO-key GAAP EPS of -$0.21, revenue of $1.9M

BIO-key press release (NASDAQ:BKYI): Q2 GAAP EPS of -$0.21. Revenue of $1.9M (+91.9% Y/Y). Outlook “BIO-key has built a strong base of products and services and a growing global footprint of partnerships and direct sales resources to address the substantial cybersecurity and IAM needs around the world. Given our progress to date and the growing scope of opportunities we are identifying, we remain confident in achieving our full-year 2022 revenue guidance of $10-13M, representing growth of over 100% above 2021. We believe BIO-key is positioned to achieve break-even operations within this range, subject to our mix of hardware and higher-margin software revenue. “Our guidance anticipates continued growth in recurring software license revenue to roughly 70% of the lower end of our revenue range, supported by hardware and services revenue contributions that are generally tied to specific projects. Our outlook is supported by our strong capital position, talented management and product development teams, and our expanding global sales, marketing and channel partner footprint.”
Analysis Article • Jun 12

Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay Packet

In the past three years, the share price of BIO-key International, Inc. ( NASDAQ:BKYI ) has struggled to grow and now...

Financial Position Analysis

Short Term Liabilities: BKYI's short term assets ($4.5M) exceed its short term liabilities ($3.2M).

Long Term Liabilities: BKYI's short term assets ($4.5M) exceed its long term liabilities ($74.6K).

Debt to Equity History and Analysis

Debt Level: BKYI has more cash than its total debt.

Reducing Debt: BKYI's debt to equity ratio has increased from 0% to 13.6% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BKYI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: BKYI has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.8% each year.

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 06:10
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BIO-key International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack Vander AardeMaxim Group